UBS
UBS is a prominent global financial services firm headquartered in Zurich, Switzerland, specializing in wealth management, investment banking, and asset management. The company serves a diverse clientele, including individuals, families, institutions, and corporations, offering tailored solutions that encompass traditional and alternative investments, real estate, and infrastructure. UBS Wealth Management provides comprehensive asset management services to both individual and institutional clients through a network of offices worldwide. Its investment banking division delivers financial advisory services, capital market access, and risk management solutions. Additionally, UBS Global Asset Management operates subsidiaries across various regions, including Asia-Pacific and Europe, focusing on investment strategies that cater to pension funds, financial intermediaries, and private clients. The firm emphasizes building trusted relationships and understanding clients' needs to deliver informed financial advice and superior investment performance.
Swixx Biopharma is a company that represents biopharma organizations in Central and Eastern Europe (CEE). Founded in 2014 and registered in Baar, Switzerland, it aims to take over the roles of subsidiaries or business units for multinational biopharma, over-the-counter (OTC), and medical device companies in regions they choose not to enter or have exited. Swixx operates with fully owned affiliates across multiple countries, including Albania, Bulgaria, Hungary, Poland, and Romania, among others. The company specializes in research-driven pharmaceutical and healthcare services, focusing on areas such as rare diseases, oncology-hematology, specialty medications, and self-medication. By leveraging its expertise, Swixx Biopharma provides comprehensive health treatment solutions tailored to the needs of the CEE market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.